I really don’t know how important this would be.
I do know that Neuren filed an international patent application two years ago for new compositions and manufacturing methods which allow substantially larger quantities of trofinetide to be produced in a way that is more commercially beneficial.
The inventors listed on this patent are drawn from Neuren, Acadia and PeptiSyntha SA Belgium/ Corden Pharma Switzerland (Corden is the parent company of PeptiSyntha). So Corden is at least a conveniently located manufacturer for any European pharma.
Under the terms of the licence, Acadia was granted a non-exclusive licence to have trofinetide manufactured outside of North America.
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021026066&_cid=P11-L9FI68-39396-4
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-2491
-
- There are more pages in this discussion • 8,951 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.21 |
Change
-0.270(1.74%) |
Mkt cap ! $1.947B |
Open | High | Low | Value | Volume |
$15.20 | $15.33 | $15.02 | $8.268M | 543.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 700 | $15.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.24 | 220 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 15.150 |
4 | 7384 | 15.130 |
1 | 1560 | 15.110 |
1 | 2177 | 15.100 |
1 | 2177 | 15.080 |
Price($) | Vol. | No. |
---|---|---|
15.240 | 220 | 1 |
15.250 | 10 | 1 |
15.270 | 1469 | 2 |
15.280 | 2177 | 1 |
15.300 | 7500 | 1 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online